Technology Update Belgium
SEE OTHER BRANDS

The best science and technology news from Belgium

Technology Update Belgium: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Update Belgium.

Press releases published on April 24, 2025

AENO Premium Eco Slimme verwarmer met REALISTISCH VUUR Effect werd bekroond met 2 Red Dot Design Awards in 2025

AENO Premium Eco Slimme verwarmer met REALISTISCH VUUR Effect werd bekroond met 2 Red Dot Design Awards in 2025

LIMASSOL, CYPRUS, April 24, 2025 /⁨EINPresswire.com⁩/ -- AENO's nieuwe product - de AENO Premium Eco Slimme verwarmer met REALISTISCH VUUR Effect - heeft twee Red Dot Awards gewonnen in de 2025 Product Design competitie. Het apparaat werd erkend in twee …

GHSO 2025: Oman’s Flagship Green Hydrogen Summit Charts Path from Promise to Progress

GHSO 2025: Oman’s Flagship Green Hydrogen Summit Charts Path from Promise to Progress

More Than a Summit—A Catalyst for National Readiness and Global Integration MUSCAT, MUSCAT, OMAN, April 24, 2025 /⁨EINPresswire.com⁩/ -- Under the Patronage of the Ministry of Energy and Minerals Green Hydrogen Summit Oman 2025 to Launch This December …

Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients

Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients

Primary endpoint met, no drug-related serious adverse events Positive hematoma and edema volume evolution Recruitment stopped early due to positive exploratory and efficacy outcomes Preparations underway to initiate Phase 2b study Gosselies, Belgium, 24 …

Bioxodes annonce des données intermédiaires positives pour son essai de phase 2a portant sur BIOX-101 dans le traitement de l’AVC hémorragique

Bioxodes annonce des données intermédiaires positives pour son essai de phase 2a portant sur BIOX-101 dans le traitement de l’AVC hémorragique

Le critère d’évaluation principal a été atteint, aucun événement indésirable grave associé au médicament n’a été rapporté L’évolution du volume de l’hématome et de l’œdème est favorable Le recrutement des patients a été arrêté plus tôt que prévu en raison …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service